chrX-154359850-C-A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_001110556.2(FLNA):c.3861G>T(p.Gln1287His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000661 in 1,209,517 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001110556.2 missense
Scores
Clinical Significance
Conservation
Publications
- periventricular nodular heterotopiaInheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- frontometaphyseal dysplasia 1Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- heterotopia, periventricular, X-linked dominantInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
- intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Melnick-Needles syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- otopalatodigital syndrome type 2Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- terminal osseous dysplasia-pigmentary defects syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- cardiac valvular dysplasia, X-linkedInheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- frontometaphyseal dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital short bowel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- otopalatodigital syndrome type 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Ehlers-Danlos syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FLNA | NM_001110556.2 | c.3861G>T | p.Gln1287His | missense_variant | Exon 23 of 48 | ENST00000369850.10 | NP_001104026.1 | |
| FLNA | NM_001456.4 | c.3861G>T | p.Gln1287His | missense_variant | Exon 23 of 47 | NP_001447.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000889 AC: 1AN: 112484Hom.: 0 Cov.: 25 show subpopulations
GnomAD4 exome AF: 0.00000638 AC: 7AN: 1097033Hom.: 0 Cov.: 33 AF XY: 0.00000551 AC XY: 2AN XY: 363015 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000889 AC: 1AN: 112484Hom.: 0 Cov.: 25 AF XY: 0.0000289 AC XY: 1AN XY: 34636 show subpopulations
ClinVar
Submissions by phenotype
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Uncertain:1
This sequence change replaces glutamine with histidine at codon 1287 of the FLNA protein (p.Gln1287His). The glutamine residue is moderately conserved and there is a small physicochemical difference between glutamine and histidine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FLNA-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at